Detail Information of Epigenetic Regulations

General Information of Drug Transporter (DT)
DT ID DTD0545 Transporter Info
Gene Name KCNK2
Transporter Name Potassium channel subfamily K member 2
Gene ID
3776
UniProt ID
O95069
Epigenetic Regulations of This DT (EGR)

Methylation

  Hepatocellular carcinoma

            6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of KCNK2 in hepatocellular carcinoma [ 1 ]

Location

 5'UTR (cg05647430)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.59E+00 Statistic Test p-value: 1.49E-17; Z-score: -3.15E+00

Methylation in Case

 3.73E-01 (Median) Methylation in Control 5.93E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of KCNK2 in hepatocellular carcinoma [ 1 ]

Location

 5'UTR (cg02543268)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.54E+00 Statistic Test p-value: 5.14E-11; Z-score: -4.11E+00

Methylation in Case

 4.36E-01 (Median) Methylation in Control 6.72E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of KCNK2 in hepatocellular carcinoma [ 1 ]

Location

 TSS1500 (cg11194108)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.09E+00 Statistic Test p-value: 1.22E-08; Z-score: -1.94E+00

Methylation in Case

 7.96E-01 (Median) Methylation in Control 8.70E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of KCNK2 in hepatocellular carcinoma [ 1 ]

Location

 TSS1500 (cg11346522)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.25E+00 Statistic Test p-value: 2.39E-07; Z-score: -1.59E+00

Methylation in Case

 4.56E-01 (Median) Methylation in Control 5.67E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of KCNK2 in hepatocellular carcinoma [ 1 ]

Location

 TSS1500 (cg20568108)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.08E+00 Statistic Test p-value: 8.87E-04; Z-score: -4.51E-01

Methylation in Case

 8.14E-01 (Median) Methylation in Control 8.77E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of KCNK2 in hepatocellular carcinoma [ 1 ]

Location

 TSS1500 (cg13107973)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.07E+00 Statistic Test p-value: 2.06E-02; Z-score: -4.22E-01

Methylation in Case

 6.34E-01 (Median) Methylation in Control 6.78E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Bladder cancer

            7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of KCNK2 in bladder cancer [ 2 ]

Location

 TSS1500 (cg20568108)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.08E+00 Statistic Test p-value: 7.15E-06; Z-score: -8.01E+00

Methylation in Case

 8.40E-01 (Median) Methylation in Control 9.06E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of KCNK2 in bladder cancer [ 2 ]

Location

 TSS1500 (cg11346522)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.56E+00 Statistic Test p-value: 9.62E-05; Z-score: -4.40E+00

Methylation in Case

 2.60E-01 (Median) Methylation in Control 4.06E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of KCNK2 in bladder cancer [ 2 ]

Location

 TSS1500 (cg13107973)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -2.11E+00 Statistic Test p-value: 1.33E-04; Z-score: -4.73E+00

Methylation in Case

 1.82E-01 (Median) Methylation in Control 3.84E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of KCNK2 in bladder cancer [ 2 ]

Location

 TSS1500 (cg11194108)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.02E+00 Statistic Test p-value: 6.01E-03; Z-score: -9.77E-01

Methylation in Case

 9.03E-01 (Median) Methylation in Control 9.21E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of KCNK2 in bladder cancer [ 2 ]

Location

 TSS200 (cg22821560)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.37E+00 Statistic Test p-value: 4.74E-03; Z-score: 2.66E+00

Methylation in Case

 5.53E-01 (Median) Methylation in Control 4.03E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of KCNK2 in bladder cancer [ 2 ]

Location

 Body (cg04923840)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.95E+00 Statistic Test p-value: 6.51E-10; Z-score: -9.85E+00

Methylation in Case

 3.39E-01 (Median) Methylation in Control 6.59E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 7

 Methylation of KCNK2 in bladder cancer [ 2 ]

Location

 Body (cg03651769)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.71E+00 Statistic Test p-value: 5.16E-08; Z-score: -7.39E+00

Methylation in Case

 4.20E-01 (Median) Methylation in Control 7.20E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Breast cancer

            8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of KCNK2 in breast cancer [ 3 ]

Location

 TSS1500 (cg13107973)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.43E+00 Statistic Test p-value: 4.84E-06; Z-score: 1.97E+00

Methylation in Case

 5.50E-01 (Median) Methylation in Control 3.86E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of KCNK2 in breast cancer [ 3 ]

Location

 TSS1500 (cg11194108)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.03E+00 Statistic Test p-value: 2.55E-04; Z-score: -6.54E-01

Methylation in Case

 8.93E-01 (Median) Methylation in Control 9.16E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of KCNK2 in breast cancer [ 3 ]

Location

 TSS1500 (cg20568108)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.03E+00 Statistic Test p-value: 3.02E-04; Z-score: -4.16E-01

Methylation in Case

 8.77E-01 (Median) Methylation in Control 9.04E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of KCNK2 in breast cancer [ 3 ]

Location

 TSS1500 (cg11346522)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.28E+00 Statistic Test p-value: 3.62E-04; Z-score: 1.37E+00

Methylation in Case

 5.09E-01 (Median) Methylation in Control 3.99E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of KCNK2 in breast cancer [ 3 ]

Location

 TSS200 (cg22821560)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.22E+00 Statistic Test p-value: 2.55E-10; Z-score: 1.71E+00

Methylation in Case

 7.01E-01 (Median) Methylation in Control 5.74E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of KCNK2 in breast cancer [ 3 ]

Location

 Body (cg04923840)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.22E+00 Statistic Test p-value: 7.50E-11; Z-score: -2.25E+00

Methylation in Case

 5.43E-01 (Median) Methylation in Control 6.64E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 7

 Methylation of KCNK2 in breast cancer [ 3 ]

Location

 Body (cg03651769)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.09E+00 Statistic Test p-value: 9.92E-04; Z-score: 8.16E-01

Methylation in Case

 7.33E-01 (Median) Methylation in Control 6.69E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 8

 Methylation of KCNK2 in breast cancer [ 3 ]

Location

 Body (cg24464500)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.11E+00 Statistic Test p-value: 8.40E-03; Z-score: 5.13E-01

Methylation in Case

 4.95E-01 (Median) Methylation in Control 4.47E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Colorectal cancer

            7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of KCNK2 in colorectal cancer [ 4 ]

Location

 TSS1500 (cg11346522)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.27E+00 Statistic Test p-value: 1.98E-06; Z-score: -1.82E+00

Methylation in Case

 6.18E-01 (Median) Methylation in Control 7.83E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of KCNK2 in colorectal cancer [ 4 ]

Location

 TSS1500 (cg13107973)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.21E+00 Statistic Test p-value: 5.96E-03; Z-score: -1.06E+00

Methylation in Case

 5.98E-01 (Median) Methylation in Control 7.22E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of KCNK2 in colorectal cancer [ 4 ]

Location

 TSS200 (cg22821560)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.20E+00 Statistic Test p-value: 7.61E-04; Z-score: -1.00E+00

Methylation in Case

 7.20E-01 (Median) Methylation in Control 8.61E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of KCNK2 in colorectal cancer [ 4 ]

Location

 Body (cg04923840)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.25E+00 Statistic Test p-value: 4.31E-08; Z-score: -2.06E+00

Methylation in Case

 5.56E-01 (Median) Methylation in Control 6.95E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of KCNK2 in colorectal cancer [ 4 ]

Location

 Body (cg03651769)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.11E+00 Statistic Test p-value: 1.75E-06; Z-score: -1.48E+00

Methylation in Case

 7.76E-01 (Median) Methylation in Control 8.59E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of KCNK2 in colorectal cancer [ 4 ]

Location

 Body (cg24464500)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.19E+00 Statistic Test p-value: 4.63E-05; Z-score: -1.48E+00

Methylation in Case

 5.59E-01 (Median) Methylation in Control 6.66E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Lung adenocarcinoma

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of KCNK2 in lung adenocarcinoma [ 5 ]

Location

 TSS1500 (cg13107973)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.23E+00 Statistic Test p-value: 5.12E-03; Z-score: 1.72E+00

Methylation in Case

 7.75E-01 (Median) Methylation in Control 6.30E-01 (Median)

Studied Phenotype

 Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of KCNK2 in lung adenocarcinoma [ 5 ]

Location

 Body (cg04923840)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.09E+00 Statistic Test p-value: 3.40E-02; Z-score: -1.88E+00

Methylation in Case

 6.27E-01 (Median) Methylation in Control 6.85E-01 (Median)

Studied Phenotype

 Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

 Patient tissue samples

  Pancretic ductal adenocarcinoma

            6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of KCNK2 in pancretic ductal adenocarcinoma [ 6 ]

Location

 TSS1500 (cg20406482)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.59E+00 Statistic Test p-value: 2.23E-10; Z-score: -2.23E+00

Methylation in Case

 2.33E-01 (Median) Methylation in Control 3.71E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of KCNK2 in pancretic ductal adenocarcinoma [ 6 ]

Location

 1stExon (cg13672791)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.14E+00 Statistic Test p-value: 9.88E-06; Z-score: 1.40E+00

Methylation in Case

 7.25E-01 (Median) Methylation in Control 6.35E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of KCNK2 in pancretic ductal adenocarcinoma [ 6 ]

Location

 Body (cg02490934)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.07E+00 Statistic Test p-value: 6.99E-06; Z-score: 9.40E-01

Methylation in Case

 7.63E-01 (Median) Methylation in Control 7.12E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of KCNK2 in pancretic ductal adenocarcinoma [ 6 ]

Location

 Body (cg01268367)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.01E+00 Statistic Test p-value: 6.12E-05; Z-score: -3.04E-01

Methylation in Case

 8.79E-01 (Median) Methylation in Control 8.90E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of KCNK2 in pancretic ductal adenocarcinoma [ 6 ]

Location

 Body (cg21843262)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.16E+00 Statistic Test p-value: 1.65E-03; Z-score: 1.53E+00

Methylation in Case

 8.56E-01 (Median) Methylation in Control 7.37E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of KCNK2 in pancretic ductal adenocarcinoma [ 6 ]

Location

 3'UTR (cg07020832)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.01E+00 Statistic Test p-value: 5.45E-06; Z-score: -5.06E-01

Methylation in Case

 8.95E-01 (Median) Methylation in Control 9.02E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Papillary thyroid cancer

            3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of KCNK2 in papillary thyroid cancer [ 7 ]

Location

 TSS1500 (cg13107973)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.74E+00 Statistic Test p-value: 1.79E-26; Z-score: 3.04E+00

Methylation in Case

 6.90E-01 (Median) Methylation in Control 3.97E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of KCNK2 in papillary thyroid cancer [ 7 ]

Location

 TSS1500 (cg11346522)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.10E+00 Statistic Test p-value: 1.25E-02; Z-score: 1.07E+00

Methylation in Case

 6.45E-01 (Median) Methylation in Control 5.84E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of KCNK2 in papillary thyroid cancer [ 7 ]

Location

 Body (cg04923840)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.02E+00 Statistic Test p-value: 6.63E-03; Z-score: -4.64E-01

Methylation in Case

 8.40E-01 (Median) Methylation in Control 8.53E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Panic disorder

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of KCNK2 in panic disorder [ 8 ]

Location

 Body (cg24464500)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 9.32E-01 Statistic Test p-value: 4.83E-02; Z-score: 1.55E-01

Methylation in Case

 -5.53E-01 (Median) Methylation in Control -5.94E-01 (Median)

Studied Phenotype

 Panic disorder [ ICD-11: 6B01]

Experimental Material

 Patient tissue samples

  Prostate cancer

            3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of KCNK2 in prostate cancer [ 9 ]

Location

 Body (cg27212234)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 6.30E+00 Statistic Test p-value: 2.22E-02; Z-score: 1.68E+01

Methylation in Case

 1.96E-01 (Median) Methylation in Control 3.11E-02 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of KCNK2 in prostate cancer [ 9 ]

Location

 Body (cg19960114)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.41E+00 Statistic Test p-value: 2.56E-02; Z-score: -8.62E+00

Methylation in Case

 4.77E-01 (Median) Methylation in Control 6.70E-01 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Liver cancer

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Significant/significant/significant hypomethylation of KCNK2 in liver cancer disease than that in healthy individual/adjacent tissue/other disease section

Studied Phenotype

 Liver cancer [ICD-11:2C12]

The Methylation Level of Disease Section Compare with the Healthy Individual

 p-value: 1.10E-08; Fold-change: -0.583045171; Z-score: -2.126803099

The Methylation Level of Disease Section Compare with the Adjacent Tissue

 p-value: 4.70E-18; Fold-change: -0.573569946; Z-score: -8.572902785

The Methylation Level of Disease Section Compare with the Other Disease Section

 p-value: 0.00649894; Fold-change: -0.315837165; Z-score: -1.112013952
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
DT methylation level in tissue other than the diseased tissue of patients
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue
Download DT methylation data of patients in the normal section of the tissue adjacent to the disease section
Download DT methylation data in the tissue of healthy individual
Download DT methylation data in the tissue of the other disease section

  Prostate cancer metastasis

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Significant hypomethylation of KCNK2 in prostate cancer metastasis than that in healthy individual

Studied Phenotype

 Prostate cancer metastasis [ICD-11:2.00E+06]

The Methylation Level of Disease Section Compare with the Healthy Individual

 p-value: 0.008185043; Fold-change: -0.405574088; Z-score: -30.77993622
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue
Download DT methylation data in the tissue of healthy individual
References
1 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
2 DNA Methylation Dynamics in Urological Tumors.
3 Genome-wide Scan for Methylation Profiles in Breast Cancer
4 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
5 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
6 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
7 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
8 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
9 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.